Cancer treatment: Ray of hope is finally here? Check details
UCLA) revealed that an innovative AI tool has demonstrated remarkable proficiency in identifying prostate cancer, achieving an accuracy rate of 84 per cent. This significantly surpasses the 67 per cent accuracy rate attained by physicians, underscoring the potential of artificial intelligence in enhancing diagnostic precision, according to a report.
Union Budget 2024 Live Updates
The findings, detailed in a press release from the university, suggest that integrating AI into medical practice could revolutionize cancer detection, providing more reliable diagnoses and potentially improving patient outcomes. This advancement marks a significant step forward in the intersection of technology and healthcare, showcasing the transformative impact of AI in modern medicine, as per the Fox News report.
Developed by Avenda Health in California, «Unfold AI» is an innovative software recently approved by the U.S. Food and Drug Administration. This advanced tool employs an AI algorithm to visualize the probability of cancer by analyzing diverse clinical data types.
By integrating various data points, Unfold AI enhances the accuracy and clarity of cancer diagnostics, potentially transforming how healthcare professionals approach cancer detection and treatment planning. The FDA's clearance of this technology underscores its potential to significantly impact patient care and outcomes in the medical field, Fox reported.
Meanwhile, US researchers have found during a study how cancer cells manage to evade
